Performance evaluation of Active Melioidosis Detect-Lateral Flow Assay (AMD-LFA) for diagnosis of melioidosis in endemic settings with limited resources

Tushar Shaw, Chaitanya Tellapragada, Vandana Ke, David P AuCoin, Chiranjay Mukhopadhyay, Tushar Shaw, Chaitanya Tellapragada, Vandana Ke, David P AuCoin, Chiranjay Mukhopadhyay

Abstract

Melioidosis is a fatal infection caused by the soil saprophyte Burkholderia pseudomallei. Early diagnosis and befitting medical management can significantly influence the clinical outcomes among patients with melioidosis. Witnessing an annual increment in the number of melioidosis cases, over the past few years, mainly from the developing tropical nations, the present study was undertaken to evaluate the diagnostic utility of Active Melioidosis DetectTMLateralFlow Assay (AMD-LFA), in comparison with enrichment culture and PCR. A total of 206clinical specimens obtained from 175 patients with clinical suspicion of melioidosis were considered for the evaluation. Positivity for B.pseudomallei using enrichment culture, PCR and AMD-LFA were observed among 63 (30.5%), 55 (26.6%) and 63 (30.5%) specimens respectively. The AMD-LFA failed to detect melioidosis from 9 culture-confirmed cases (6 whole blood specimens, 2 pus samples, and one synovial fluid). Further the test gave faint bands from 9 urine samples which were negative by culture and PCR. AMD-LFA demonstrated a sensitivity, specificity, of 85.71%(CI:74.61% to 93.25%) and 93.62% (CI:88.23% to 97.04%), with positive predictive value of 85.71% (CI: 75.98% to 91.92%) and negative predictive value of 93.62% (CI:88.89% to 96.42%). The test needs further evaluation in view of the faint bands from negative urine samples, for incorporating the test as a point of care assay.In view of its rapidity and ease of testing AMD-LFA might be useful in early diagnosis of melioidosis at resource constraint settings.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
AMD-LFA test showing a) faint bands and b) strong bands.
Fig 2. Receiver operating characteristic curve for…
Fig 2. Receiver operating characteristic curve for AMD-LFA and PCR in comparison with enrichment culture.

References

    1. Limmathurotsakul D, Wongratanacheewin S, Teerawattanasook N, Wongsuvan G, Chaisuksant S, Chetchotisakd P, et al. Increasing incidence of human melioidosis in Northeast Thailand. The American journal of tropical medicine and hygiene. 2010. June 1;82(6):1113–7. doi:
    1. Currie BJ, Fisher DA, Howard DM, Burrow JN, Selvanayagam S, Snelling PL, et al. The epidemiology of melioidosis in Australia and Papua New Guinea. Actatropica. 2000. Feb 5;74(2):121–7.
    1. Mukhopadhyay C, Chawla K, Krishna S, Nagalakshmi N, Rao SP, Bairy I. Emergence of Burkholderia pseudomallei and pandrug-resistant non-fermenters from southern Karnataka, India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2008. December 1;102(Supplement_1):S12–7.
    1. Vidyalakshmi K, Lipika S, Vishal S, Damodar S, Chakrapani M. Emerging clinico-epidemiological trends in melioidosis: analysis of 95 cases from western coastal India. International Journal of Infectious Diseases. 2012. July 31;16(7):e491–7. doi:
    1. Tellapragada C, Shaw T, D'Souza A, Eshwara VK, Mukhopadhyay C. Improved detection of Burkholderia pseudomallei from non‐blood clinical specimens using enrichment culture and PCR: Narrowing diagnostic gap in resource constrained settings. Tropical Medicine & International Health. 2017. May 16.
    1. Limmathurotsakul D, Golding N, Dance DA, Messina JP, Pigott DM, Moyes CL et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature microbiology. 2016. January 11;1:15008.
    1. O'Brien M, Freeman K, Lum G, Cheng AC, Jacups SP, Currie BJ. Further evaluation of a rapid diagnostic test for melioidosis in an area of endemicity. Journal of clinical microbiology. 2004. May 1;42(5):2239–40. doi:
    1. Walsh AL, Smith MD, Wuthiekanun V, Suputtamongkol Y, Desakorn V, Chaowagul W, White NJ. Immunofluorescence microscopy for the rapid diagnosis of melioidosis. Journal of clinical pathology. 1994. April 1;47(4):377–9.
    1. Houghton R.L, Reed D.E, Hubbard M.A, Dillon M.J, Chen H, Currie B.J, et al. (2014). Development of a prototype lateral flow immunoassay (LFI) for the rapid diagnosis of melioidosis. PLoSNegl Trop Dis, 8(3), p.e2727.
    1. Winstanley C, Hart CA. Presence of Type III Secretion Genes in Burkholderia pseudomallei Correlates with Ara− Phenotypes. Journal of clinical microbiology. 2000. February 1;38(2):883–5.
    1. Supaprom C, Wang D, Leelayuwat C, Thaewpia W, Susaengrat W, Koh V, et al. Development of real-time PCR assays and evaluation of their potential use for rapid detection of Burkholderia pseudomallei in clinical blood specimens. Journal of clinical microbiology. 2007. September 1;45(9):2894–901. doi:
    1. Robertson G, Sorenson A, Govan B, Ketheesan N, Houghton R, Chen H, et al. Rapid diagnostics for melioidosis: a comparative study of a novel lateral flow antigen detection assay. Journal of medical microbiology. 2015. August 1;64(8):845–8. doi:
    1. Hoffmaster AR, AuCoin D, Baccam P, Baggett HC, Baird R, Bhengsri S, et al. Melioidosis diagnostic workshop, 2013. Emerging infectious diseases. 2015. February;21(2).

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi